openPR Logo
Press release

PEGylated Proteins Market - Competitive Landscape and Key Product Segments

PEGylated Proteins Market

PEGylated Proteins Market

The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in blood and stability of drug. A variety of therapeutic peptides, proteins, and small drug molecules have been PEGylated to improve or alter pharmacokinetic parameters in order to benefit from various consequences.

View Report Overview -
https://www.transparencymarketresearch.com/pegylated-proteins-market.html

The controlled releasable PEGs have been aimed to avoid any loss of efficacy by controlling the release of native protein from the conjugates into the blood. PEGylation of therapeutic proteins has enhanced the management of several chronic diseases, including cancer, leukemia, hepatitis C, rheumatoid arthritis, severe combined immunodeficiency disease, and Crohn’s disease. Pegaspargase, pegademase bovine, pegfilgrastim, certolizumab pegol, pegvisomant, pegaptanib, and interferons are the most important PEGylated drugs. Some of PEGylated products are in various development stages. The applications and rising adoption of PEGylation to treat various chronic diseases are likely to drive the PEGylated proteins market during the forecast period.

The PEGylated Proteins Market can be segmented based on product type, application, process, end-user, and region. In terms of product type, the market can be segmented into services and consumables. The services segment includes development, production, process developments, and feasibility study of PEGylate, and process of PEGylation. The consumables segment includes PEGylation kits and reagents.

In terms of application, the PEGylated proteins market can be segmented into hepatitis, hemophilia, cancer, multiple sclerosis, gastrointestinal disorder, and others. The others segment includes protein drug delivery and other diseases. Increasing prevalence of chronic diseases is likely to drive the PEGylated proteins market during the forecast period. PEGylated proteins increase the stability of drug in body and gives better action as compared with normal drug. Presently, PEGylation is used for chemotherapy due to its associated benefits.

Based on process, the market can be segmented into chemical PEGylation, enzymatic PEGylation, and genetic PEGylation. These are main techniques or processes used in preparation of PEGylated proteins. End-users of PEGylated proteins are pharmaceutical & biotechnology companies, contract research organizations, and academic research institutes. The pharmaceutical and biotechnology companies segment is expected to witness fastest growth during the forecast period led by increasing R&D spending in pharmaceutical and biotechnology sectors globally.

To obtain all-inclusive information on forecast analysis of Global PEGylated Proteins Market, Request a PDF Brochure Here -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18539

Rising adoption of protein based drugs over non-protein based drugs is the key factor likely to drive the PEGylated proteins market during the forecast period. PEGylated proteins have wide applications and advantages over traditional therapy, and hence the adoption is high.

Other factors such as increasing research and development funding by governments of different countries, growth of biological sector, and increasing protein stability and solubility are attributed to the growth of the PEGylated proteins market. Factors such as failure of drug development and recall of products are expected to hamper the PEGylated proteins market during the forecast period.

Major players in the PEGylated proteins market are Merck Millipore, Thermo Fisher Scientific, Inc., JenKem Technology, Celares GmbH, Biomatrik, Inc., Laysan Bio, Inc., Laysan Bio, Inc., and Creative PEGWorks.

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PEGylated Proteins Market - Competitive Landscape and Key Product Segments here

News-ID: 1846444 • Views: 196

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for PEGylate

Rising Adoption of PEGylation to Treat Various Chronic Diseases are Likely to Dr …
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in
PEGylated Proteins Market driven by increasing prevalence of lifestyle diseases
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in
PEGylated Proteins 2024 Market Research Report
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in
PEGylated Proteins Market Size, Status & Forecast 2024
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in
New study: PEGylated Proteins Market Trends, Business Strategies and Opportuniti …
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in
PEGylated Proteins Market Outlook Key Analysis and Forecast by 2024
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in